RESULTS: SA patients have an 8.9% incidence of nephrolithiasis, compared to 5.5% of the non-SA control (p<0.001). SA patients also have higher rates of metabolic comorbidities (p<0.001). After adjusting for age, gender and comorbidities, the risk of nephrolithiasis remained significantly increased in the SA group (hazard ratio [HR]¼1.35; 95% confidence interval [CI]¼1.23-1.47; p<0.001). Greater HRs of nephrolithiasis were observed for male patients (1.21; 95% CI¼1.09-1.35; p<0.001) and those aged 20-39 years (1.25; 95% CI¼1.06-1.46; p<0.01) in the SA cohort. Risk of nephrolithiasis in SA patients increased significantly with concomitant diabetes mellitus, hypertension, hyperlipidemia, and morbid obesity.
INTRODUCTION AND OBJECTIVES: Higher serum calcium (Ca) and/or parathyroid hormone (PTH) in patients with kidney stones raises the suspicion for primary hyperparathyroidism (PHPT), however the diagnosis can be challenging to confirm. We sought to determine if patients can be risk stratified regarding likelihood of PHPT based on blood and urine studies.
METHODS: We queried our electronic medical record for patients with ICD-9 codes for both PHPT and kidney or ureteral stones. In an effort to identify patients with a suspicion of PHPT we also included patients with a serum Ca >9.9 mg/dL, PTH >50 pg/ml, and kidney or ureteral stones. Patients with kidney transplant or prior parathyroidectomy were excluded. From the medical record we extracted demographics, lab and urine values at presentation and at follow-up visits, parathyroid Imaging, details of parathyroidectomy, and postoperative lab values when appropriate.
RESULTS: We divided the 147 patients into three groups based on serum Ca and PTH: classic, suspicious, and not suspicious for PHPT. The classic group (n¼30) had high Ca (>10.2mg/dL) and high PTH >65 (pg/ml) simultaneously during follow-up. The suspicious group (n¼53) had a Ca 9.9 and a PTH 50 simultaneously during follow-up. The non-suspicious group (n¼64) never had a Ca 9.9 and a PTH 50 simultaneously during follow-up. We further subdivided the suspicious group into three groups: Group S1 (n¼20) with high normal Ca (9.9-10.1mg/dL) and high normal PTH (50-64pg/ml), Group S2 with high normal Ca and high PTH (n¼22), and Group S3 (n¼11) with high Ca and high normal PTH. There was no significant difference in the maximum urine Ca across groups. In the classic group 100% had parathyroid imaging, 80% of which was positive. In the suspicious group 47% had imaging 52% of which was positive. Parathyroidectomy was performed in 83.3% of classic, 30% of S1, 27%, of S2, 45% of S3 and 9.4% of the not suspicious groups. Serum Ca normalized in 100% of patients who underwent surgery. The classic group had the shortest time to imaging and surgery but this did not reach significance (p¼0.2).
CONCLUSIONS: Half of patients who undergo parathyroidectomy had a non-classic presentation, suggesting that we are underdiagnosing PHPT. Although both Ca and PTH are considered when making the diagnosis of PHPT, in our study group serum Ca seemed to more frequently drive the diagnosis supporting the AUA guidelines on the selective use of PTH. Efforts should be made to pursue a better diagnostic algorithm for the diagnosis of PHPT. Alan Carnes*, Augusta, GA; Zach Klaassen, Toronto, Canada; Michael Kemper, Durwood Neal, Vinata Lokeshwar, Augusta, GA INTRODUCTION AND OBJECTIVES: Demographic studies on renal calculi have suggested an increasing incidence of nephrolithiasis. Although these studies have used large national databases, none have examined data from within the last decade and have suggested that the closing gender gap is due to an increased incidence of calculi in females. The purpose of this study was to examine the most recent data from the Nationwide Inpatient Sample database to investigate the recent trends of gender and race in this pervasive disease.
Source of Funding: none
METHODS: Patient data of 459,823 discharges from 2000 to 2013, with a primary International Classification of Diseases, 9th revision principal diagnosis code of 592.0 (calculus of kidney) or 592.1 (calculus of ureter) were included in the study. Only patients with a designation of either "male" or "female" were included in the study. Racial groups were divided into White, Black, Hispanic, Asian, Native American, or other/not recorded. Trend analysis was performed, and fit lines were generated using a linear regression model to compute statistical significance. A subgroup analysis, with respect to gender, was performed for each race.
RESULTS: The 459,823 discharges included 243,223 from men and 216,600 from women. Within the 13-year study period, total discharges for renal and ureteral calculi decreased by 19.1% with a statistically significant, 1.7% decrease in incidence per year (p ¼0.0001). Calculi in men decreased by an average of 2.2% per year for a total of 30.5% decrease in incidence in the study period (p <0.0001). However, the incidence of calculi in women was variable without any significant trend. Sub-group analysis by race revealed that renal and ureteral calculi were more common in Black females and Hispanic females when compared to their male counterparts. The incidence of stones grew by an average of 2.7% per year in Black women (p< 0.002) and 4.6% per year in Hispanic women (p< 0.0001). This resulted in a 50.4% increase in incidence in each group between 2000 and 2013.
CONCLUSIONS: While data from earlier years had suggested that the incidence of stone disease was increasing, our analysis of recent data show that the incidence of renal and ureteral calculi resulting in medical intervention (evaluation by a physician, admission, etc.) is decreasing. This trend is attributable to a decrease in stone disease in men, resulting also in a decreased male-to-female ratio of stone disease from 1.3:1 to about 1:1. This study also reveals interesting trends in the racial demographics of stones with Black and Hispanic women now experiencing up to 50% more stone disease than their male counterparts. Lael Reinstatler*, Sari Khaleel, Vernon Pais, Lebanon, NH INTRODUCTION AND OBJECTIVES: Lithogenic urinary changes occur during pregnancy. Such changes may increase stone proclivity in working and child rearing aged women thereafter. However, such an association has not been previously identified.
METHODS: We analyzed nationally representative data from the 2007-2012 National Health and Nutrition Examination Survey to assess for an association between pregnancy and nephrolithiasis.
RESULTS: The weighted national prevalence of nephrolithiasis among women ¼50 was 6.4% (95% Confidence Interval (CI) 5.4%-7.6%). The prevalence of nephrolithiasis was significantly higher among women who had been pregnant compared with those who had never been pregnant (7.5% vs 3.2%, p¼0.0004). On univariate regression, Vol. 197, No. 4S, Supplement, Tuesday, May 16, 2017 THE JOURNAL OF UROLOGY â e1289 those who had been pregnant had over twice the odds of having had kidney stones (OR 2.44, 95% CI 1.50-3.98). An increased likelihood of nephrolithiasis among those with history of pregnancy persisted on multivariable logistic regression adjusting for age, ethnicity, obesity, history of diabetes, gout, hormone use, water intake and high sodium diet (OR 2.13, 95% CI 1.31-3.45). Finally, the adjusted prevalence of nephrolithiasis increased significantly with increasing number of pregnancies, from 5.2% in those with 0 reported pregnancies to 12.4% in those with 3 or more pregnancies (p¼0.001). CONCLUSIONS: Nephrolithiasis is strongly associated with prior pregnancies. Among women of reproductive age, the odds of stones are greater than doubled in those who had been pregnant compared with those never pregnant. Nephrolithiasis prevalence also increases with increasing number of pregnancies. Future investigation and identification of modifiable risk factors among pregnant patients may allow reduction in burden of stone disease in women.
Source of Funding: None

MP95-11 EVALUATION, MANAGEMENT, AND OUTCOMES OF PREGNANT PATIENTS WITH CLINICALLY SYMPTOMATIC NEPHROLITHIASIS AT A LARGE WOMEN'S HOSPITAL
Nabeel Hamoui*, Emily Yura, Mary Kate Keeter, Kaitly Sacotte, Beverely Onyekwuluje, Nirali Shah, Chicago, IL; Granville Lloyd, Denver, CO; Stephanie J. Kielb, Chicago, IL INTRODUCTION AND OBJECTIVES: To review the evaluation and management of pregnant patients with clinically symptomatic nephrolithiasis evaluated at a single institution over a 14-year period.
METHODS: A retrospective chart review was performed to identify pregnant patients admitted with a diagnosis of nephrolithiasis at a single institution from 2002-2016. Admission rates, lengths of stay, rates of sepsis, utilization of imaging, administration of MET, rates and type of surgical intervention, and gestational outcomes were analyzed through the patient 0 s gestational period.
RESULTS: 695 pregnant patients with symptomatic nephrolithiasis were identified, 304 of whom delivered at our institution and were included in the analysis. Average maternal age was 30.4 years (range 17-48). Of these, 262 (86.2%) had imaging interpreted as consistent with nephrolithiasis. 261 (85.9%) underwent US, 16 (5.3%) CT scan, and 4 (1.3%) MRI. The remaining 42/304 patients (13.8%) were diagnosed based on history and symptoms alone. 40 patients (13.2%) were started on tamsulosin during their pregnancy. 242 (80%) patients had culture data, 33/242 (13.6%) which were positive. 32 (10.5%) patients underwent surgical management, 2 in the first trimester, 17 in the second, and 13 in the third. Patients were more likely to receive definitive surgical management in the first trimester (2/2, 100%) versus 10/30 (33.3%) later in pregnancy (p<0.05). 6/32 (18.8%) of patients in the surgical group presented with 2 SIRS criteria. Patients in the MET group were more likely to undergo surgical management (p<0.05). There was a statistically significant correlation between the rate of operative intervention and the number of hospital encounters (p<0.05) as well as length of stay (p<0.05). No statistically significant correlation was seen in the rates of preterm labor or APGAR scores in patients who underwent surgery versus those who did not.
CONCLUSIONS: To our knowledge, this is the largest study focused on the management of symptomatic nephrolithiasis in pregnant women. The majority of patients had a diagnosis confirmed by imaging, primarily with ultrasound. Definitive surgical management was more likely to occur in the first trimester. Patients receiving MET were more likely to require surgical intervention. Surgical intervention was not associated with preterm labor or low APGAR scores. Recent studies suggest that stone etiology in this population has shifted from purely infectious to mixed infectious/metabolic. We assess a cohort of NDMD patients for metabolic lithogenic risk factors, trends across etiology of NDMD, as well as trends across primary stone type.
Source of Funding: None
METHODS: We conducted a retrospective cohort study of NDMD patients presenting to our dedicated 0 stone clinic 0 from 2000-2015. Patients with chemical stone and 24-hour urine analysis were included. Demographics, neurological deficiency, bladder management strategy, urine cultures, 24-hour urine, and stone composition were reviewed.
RESULTS: Seventy eight patients with NDMD and nephrolithiasis were identified. Of these, 26 had both chemical stone and 24 hour urine analysis. Positive urine cultures prior to treatment were present in 77%. Eighty-five percent of these cultures were positive for urea splitting organisms. The most common stone type categorized by primary composition was carbonate apatite (53.8%) followed by mixed apatite/oxalate (19.2%). When categorized by primary etiology, 61.5% were pure pH dependent (presumed to be infectious), 27% mixed pH dependent/metabolic, and 11.5% pure metabolic. Urinary citrate was significantly lower in patients with carbonate apatite, or pH dependent, calculi. Those with primarily calcium oxalate stones were significantly more likely to be obese (p¼0.003), with a mean body mass index of 37. When stratified by gender, males were more likely to have hyperoxaluria. There was a trend toward positive cultures for urea splitting organisms and carbonate apatite stones in catheterized patients. Otherwise, there were no statistically significant differences in 24-hour urine parameters when stratified by gender, neurological deficiency, or bladder management strategy.
CONCLUSIONS: Among NDMD patients, metabolic factors may play a more significant role in stone formation than previously believed. There is still a high incidence of carbonate apatite stones, which could be attributed to bacteriuria and elevated pH. In addition to this, obesity, low volumes, low citrate, and elevated oxalate suggest a metabolic etiology. Identifying metabolic risk factors in NDMD patients is challenging but important; as it may significantly impact stone recurrence and the need for repeat surgery.
